Want to see GRCE full AI Analyst Report?
Grace Therapeutics (GRCE) Q4 2026 Earnings Report
GRCE Q4 2026 EPS Results
- Actual EPS
- -$0.06
- Consensus EPS
- -$0.23
- Beat/Miss
- Beat by +$0.17
- One Year Ago EPS
- $0.11
GRCE Q4 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2026
- Date
- 06/18/2026
- Time
- Before Open
- Conference Call
- Thursday, June 18, 2026
GRCE Upcoming Earnings
Grace Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q4 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
GRCE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2027 (Q2) | -0.15- | -0.06 | ― | ― |
| Aug 13, 2026 | 2027 (Q1) | -0.13-0.91 | -0.21 | -333.33% (-0.70) | |
| Jun 18, 2026 | 2026 (Q4) | -0.23-0.06 | 0.11 | -154.55% (-0.17) | |
| Feb 12, 2026 | 2026 (Q3) | -0.28-0.14 | -0.36 | 61.11% (+0.22) | |
| Nov 13, 2025 | 2026 (Q2) | -0.25-0.06 | -0.3 | 80.00% (+0.24) | |
| Aug 12, 2025 | 2026 (Q1) | -0.22-0.21 | -0.24 | 12.50% (+0.03) | |
| Jun 23, 2025 | 2025 (Q4) | -0.280.11 | -0.17 | 164.71% (+0.28) | |
| Feb 13, 2025 | 2025 (Q3) | -0.34-0.36 | -0.21 | -71.43% (-0.15) | |
| Nov 13, 2024 | 2025 (Q2) | -0.37-0.30 | -0.43 | 30.23% (+0.13) | |
| Aug 09, 2024 | 2025 (Q1) | -0.27-0.24 | -0.54 | 55.56% (+0.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
